Pre-conference program provided recommendations for oncology pharmacy management strategies.
During the last two decades, managed care organizations (MCOs) have spent a considerable amount of time and resources managing prescription drug costs for large chronic disease categories.
Utilizing the management of multiple myeloma as an example, the pre-conference program, entitled “The Evolving Oncology Pharmacy Paradigm: Emerging Strategies for Managed Care Professionals,” recommended emerging oncology pharmacy management strategies and methods for managed care professionals to implement within their current setting as well as extrapolate to other types of cancer as needed.
This program included a distinguished panel of thought leaders such as David H. Vesole, MD, PhD, Hackensack University Medical Center; David G. Frame, PharmD, University of Michigan Health System; C. Daniel Mullins, PhD, University of Maryland School of Pharmacy; and Jeffrey D. Dunn, PharmD, MBA, SelectHealth.
Dr. Vesole explained the use of decision-support tools that utilize evidence-based treatment management plans for patients with multiple myeloma in a managed care setting. Dr. Frame described managed care strategies and methods, comparing and contrasting oncology versus traditional pharmacy management for patients with chronic illnesses. Dr. Mulllins identified techniques for MCOs to determine the cost-effectiveness and survival benefits of multiple myeloma therapies. Finally, Dr. Dunn explained emerging programs and methods that MCOs can implement to improve overall oncology patient outcomes.
Because managed care leaders have identified oncology drugs and biologics as priority areas for managing costs, further discussion is crucial to develop and implement new strategies, coordinate oncology care through case management, educate patients about treatment with current and emerging cancer drugs, and collaborate effectively with specialty pharmacy management.
For more information about this program, please visit www.amcp.org.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More